Tuberculosis in Dominica

Tuberculosis (TB), once referred to as consumption or the White Plague, remains a persistent, though manageable, public health priority in the Commonwealth of Dominica. As a chronic infectious disease caused by the bacterium Mycobacterium tuberculosis, TB primarily affects the lungs but can disseminate to almost any organ in the human body. In the specific context of the nature isle, the history of TB reflects the island’s broader transition from a colony struggling with basic infectious disease control to a modern state utilising advanced molecular diagnostics. While Dominica is classified by the World Health Organization (WHO) as a low-burden country for TB, the disease’s persistence is closely linked to the island’s demographic shifts, the prevalence of HIV, and the rising rates of non-communicable diseases like diabetes.

Today, Dominica continues to refine its National Tuberculosis Program (NTP) to meet the ambitious global targets of the WHO “End TB Strategy,” focusing on early detection, universal access to treatment, and the elimination of social stigma.

Historical Context and the Pre-Antibiotic Era

The history of tuberculosis in Dominica over the last 100 years is a story of medical triumph over a once-certain death sentence. In the 1920s and 1930s, tuberculosis was a major cause of death on the island, exacerbated by poor housing conditions, malnutrition, and a total lack of effective pharmaceutical intervention. During this era, the diagnosis was almost entirely clinical, based on the classic symptoms of persistent cough, hemoptysis (coughing up blood), night sweats, and wasting away.

At that time, the only available treatment was the sanatorium model. Patients were often isolated in specialised wards or chest clinics where the primary prescription was fresh air, rest, and a high-calorie diet. In Dominica, this isolation was often forced by social stigma; families would frequently hide infected relatives to avoid the ostracisation of the entire household. The introduction of the BCG (Bacillus Calmette-Guérin) vaccine in the mid-20th century marked the first major milestone in preventive medicine. Dominica began implementing widespread BCG vaccination for newborns in the 1950s, a policy that remains a cornerstone of the National Immunisation Registry today.

The 1950s also saw the arrival of the first effective anti-TB drugs, such as Streptomycin and later Isoniazid and Rifampicin. These miracle drugs transformed TB from a lifelong, often fatal affliction into a curable infection. However, the requirement for long-term treatment, often lasting six to nine months, created a new challenge: patient adherence. This historical difficulty eventually led to the adoption of the DOTS (Directly Observed Treatment, Short-course) strategy, which remains the international standard for management in Dominica’s district health centers.

Epidemiology and Statistical Analysis: 1990 to 2026

To understand the current status of TB in Dominica, one must review the multi-year statistical data provided by the Ministry of Health and the Pan American Health Organization (PAHO). Dominica’s small population (approximately 72,000) means that even a handful of cases can significantly affect incidence rates per 100,000 people.

Incidence and Prevalence Trends

Over the last three decades, Dominica has maintained a relatively low but stable TB incidence.

• 1990–2000: The incidence rate fluctuated between 10 and 15 cases per 100,000 inhabitants. During this decade, the primary risk factors were poverty and overcrowding in urban areas like Roseau and Portsmouth.
• 2000–2015: With the expansion of the primary healthcare network, the incidence stabilized. By 2010, the island reported roughly 5 to 8 new cases annually.
• 2020–Current: Recent data indicate a slight but notable uptick in cases, often attributed to improved diagnostic sensitivity (finding cases that were previously missed) and the double burden of TB and HIV. In 2024, Dominica reported 9 new cases, translating to an incidence rate of approximately 12.5 per 100,000.

Mortality and Success Rates

The mortality rate for TB in Dominica has dropped significantly since the pre-antibiotic era. In the 1930s, TB mortality was estimated to be as high as 100 per 100,000. By 2026, TB-related deaths are rare, typically occurring only in cases of extreme late presentation or severe co-infection.

• Treatment Success Rate: Dominica consistently achieves a treatment success rate of over 85% for new pulmonary TB cases.
• Default Rate: One of the key metrics tracked by the National TB Program is the default rate (patients who stop taking medication). In Dominica, this rate is kept below 5% through the diligent work of district nurses who perform home visits to ensure compliance.

The National Tuberculosis Program (NTP) Infrastructure

Dominica’s response to TB is coordinated through a centralised program that operates via the decentralised primary healthcare network. This structure ensures that a patient in a remote village like La Plaine or Grand Fond has the same access to care as someone in the capital.

The Role of the District Health Centers

The 52 health centers across Dominica’s seven health districts are the frontline of TB surveillance. Every Dominican citizen presenting with a cough of 2 weeks or more is automatically classified as a TB suspect and is placed in a diagnostic algorithm. District nurses are responsible for collecting sputum samples and, crucially, administering DOTS. Under DOTS, the patient must be observed by a healthcare provider or a trained community member while swallowing their medication. This ensures that the full course is completed and prevents the development of drug resistance.

The Dominica China Friendship Hospital (DCFH) and Diagnostics

The DCFH serves as the tertiary hub for TB management. The transition from the old Princess Margaret Hospital to the DCFH has brought state-of-the-art diagnostic technology to the island.

• GeneXpert MTB/RIF: In the past, Dominica relied on sputum smear microscopy, which could miss cases with a low bacterial load. Today, the national lab utilises GeneXpert molecular testing. This technology can detect Mycobacterium tuberculosis DNA and identify Rifampicin resistance (the most important anti-TB drug) in less than 2 hours.
• Radiology: Digital X-ray facilities at the DCFH and the Reginald Fitzroy Armour Hospital enable rapid screening of pulmonary abnormalities that may suggest TB even when sputum tests are negative.

TB/HIV Co-infection: The Lethal Synergy

The most significant challenge to TB control in modern Dominica is the interaction between TB and the Human Immunodeficiency Virus (HIV). HIV weakens the immune system, making an individual significantly more likely to progress from a latent TB infection (where the bacteria are dormant) to active TB disease.

Statistical data from the last 15 years show that approximately 15% to 20% of TB patients in Dominica are also HIV-positive. This co-infection requires a highly coordinated clinical approach. The Ministry of Health mandates that all TB patients be screened for HIV, and all HIV patients be screened for TB at every clinic visit. The One-Stop-Shop model of care, where patients receive their antiretroviral therapy (ART) and their anti-TB medication at the same facility, has been instrumental in improving survival rates for co-infected individuals.

Multidrug-Resistant Tuberculosis (MDR-TB)

Multidrug-resistant TB (MDR-TB) is a form of the disease that does not respond to at least Isoniazid and Rifampicin, the two most powerful first-line drugs. MDR-TB is a global health threat, often caused by inconsistent or partial treatment of standard TB.

In Dominica, MDR-TB remains extremely rare, with only sporadic cases recorded over the last decade. This rarity is a direct result of the DOTS program’s high success rate. However, the Ministry of Health remains vigilant. Because the treatment for MDR-TB is much longer (up to 24 months), more toxic, and significantly more expensive, the national strategy focuses on first-time cure to prevent resistance from ever developing. In the event of an MDR-TB case, Dominica coordinates with PAHO to procure second-line medications and specialised laboratory support for drug-susceptibility testing.

TB and Diabetes: The Emerging Double Burden

While the link between TB and HIV is well-known, a newer and equally concerning trend in Dominica is the link between TB and Diabetes Mellitus. As discussed in the context of the island’s NCD crisis, Dominica has high rates of Type 2 diabetes.

Research indicates that people with diabetes are three times more likely to develop TB. Diabetes impairs the immune response and can complicate TB treatment, leading to longer recovery times and a higher risk of relapse. The National TB Program has recently begun integrating blood glucose screening for all TB patients, recognising that uncontrolled blood sugar makes the Nature Island’s population more vulnerable to infectious outbreaks.

Key Figures in TB Management and Advocacy

The success of Dominica’s TB program is built on the dedication of several key medical professionals and public health leaders.

• Dr. Kyra Paul: As Chief Medical Officer, she has overseen the modernisation of the national diagnostic protocols and ensured that TB remains a priority on the national health agenda despite the low number of cases.
• The National TB Coordinator: This role (historically held by dedicated senior nurses and physicians) is responsible for the meticulous tracking of every TB suspect on the island. Their work involves maintaining the National TB Register, a comprehensive database that tracks patient outcomes from diagnosis to cure.
• The District Nurses: The unnamed heroes of TB control in Dominica are the district nurses. In a small society where a TB diagnosis can still bring shame, these nurses act as counselors, educators, and clinicians, traveling to mountainous villages to ensure their patients stay on the path to recovery.

Social Stigma and Cultural Perceptions

In Dominica, the social weight of a TB diagnosis is often heavier than the physical symptoms. The historical memory of the “Chest Wards” and the fear of a highly contagious, wasting disease persist in the collective consciousness.

Patients often report fear of losing their jobs or being shunned by their neighbours if their status becomes known. This stigma can lead to a delay in health-seeking behaviour; a person might cough for months and attempt to treat themselves with bush medicine rather than visit a clinic and risk a TB diagnosis.

• Traditional Remedies: Common Dominican herbs like Zebapique (Zèb Malad) or various ginger and honey concoctions are often used to treat respiratory ailments. While these are culturally significant and can soothe symptoms, they cannot kill the TB bacilli. Public health education focuses on integrative awareness, encouraging residents to use their traditional teas, but first to get a professional diagnosis if a cough persists.

Climate Resilience and Tuberculosis

Dominica’s vulnerability to extreme weather events, such as Hurricane Maria in 2017, has forced the National TB Program to develop a climate-resilient framework. When a major hurricane strikes, the primary concerns for TB control are:

1. Treatment Interruption: If roads are blocked or clinics destroyed, patients cannot receive their DOTS. This creates a high risk for the development of drug resistance.
2. Crowding in Shelters: Post-disaster displacement often leads to people living in crowded emergency shelters. In these environments, an undiagnosed or untreated TB patient can quickly infect others, leading to a localized outbreak.

Following 2017, the Ministry of Health implemented Emergency TB Packs, pre-packaged three-month medication supplies stored in hurricane-proof containers across the health districts. Furthermore, the electronic Case-Based Surveillance system is now backed up on cloud servers to ensure that patient records are not lost if physical files are destroyed.

Economic Impact of Tuberculosis

While the number of TB cases in Dominica is low, the economic impact per case is high. Because TB primarily affects the lungs and causes severe fatigue, it removes individuals from the workforce for months at a time.

• Direct Costs: The government of Dominica provides all TB diagnostics and medications free of charge. This is a significant investment, as the cost of a standard 6-month course of treatment can exceed several hundred dollars per patient, while MDR-TB treatment can cost thousands.
• Indirect Costs: The loss of productivity and the catastrophic costs to a household (transportation to clinics, loss of the primary breadwinner’s income) can push a Dominican family into poverty. The Social Welfare Division often works alongside the Ministry of Health to provide nutritional support packages to TB patients to ensure they have the caloric intake needed to tolerate the heavy medication regimen.

The Future: The WHO End TB Strategy in Dominica

As Dominica looks toward 2030 and 2035, the goal is not just management but elimination. The WHO defines elimination as fewer than 1 case per million people, a target that is mathematically challenging for a population of 72,000 but a goal that represents the ultimate standard of care.

Targets for 2030/2035:

• 95% reduction in TB deaths compared to 2015 levels.
• 90% reduction in TB incidence rate (less than 10 per 100,000).
• 0% of TB-affected households facing catastrophic costs due to the disease.

To achieve this, Dominica is focusing on the management of latent tuberculosis infection (LTBI). This involves testing the close contacts of active TB patients, family members, coworkers, and schoolmates, and providing preventative therapy to those who test positive for the bacteria but do not yet have the disease. By treating the reservoir of dormant bacteria, Dominica aims to prevent new cases of active TB in the coming decades.

Statistical Summary and Comparison Table

Metric	1926 (Estimated)	2000 (Reported)	(Current Status)
Annual Incidence (Cases)	~150+	11	9
Incidence per 100k	~200+	15.3	12.5
HIV Co-infection Rate	N/A	~9%	~18%
Treatment Success Rate	~10-20%	82%	89%
Diagnostics Used	Clinical Exam only	Smear Microscopy	GeneXpert Molecular / AI-Xray
BCG Vaccine Coverage	0%	98%	99%
MDR-TB Cases	0	0	0 (Sporadic)

A Manageable Threat

Tuberculosis in Dominica is a manageable threat, held in check by one of the most robust primary healthcare systems in the Caribbean. The island has successfully moved from the dark days of the sanatorium and the White Plague to a modern era of molecular diagnostics and 90% cure rates. However, the fight is not over. The synergy between TB and HIV, the added complication of high diabetes rates, and the constant threat of climate-driven disruption require a healthcare system that is both vigilant and resilient. Through the continued dedication of the National TB Program, the support of international partners like PAHO, and a national commitment to destigmatising the disease, Dominica is well-positioned to meet the global goal of ending TB once and for all.